P. Van Rooy
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- Epidemiology top 5%
- Nail Diseases and Treatments
- Fungal Infections and Studies
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
-
- Pain Mechanisms and Treatments 2
- Co-authors
- G. Cauwenbergh (4 shared papers)R. Woestenborghs (2 shared papers)J. Heykants (2 shared papers)A. Van Peer (1 shared paper)Vera Van de Velde (1 shared paper)Karel Lavrijsen (1 shared paper)J. Van Cutsem (1 shared paper)W. Meuldermans (1 shared paper)
- Journals
- Diabetologia (2 papers)The Prostate (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)European Journal of Clinical Pharmacology (1 paper)Mycoses (1 paper)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
P. Van Rooy
18 papers receiving 821 citations
Peers
Comparison fields: 5 of 94
- Infectious Diseases 361
- Epidemiology 400
- Pharmaceutical Science 79
- Small Animals 74
- Pharmacology 74
Countries citing papers authored by P. Van Rooy
This map shows the geographic impact of P. Van Rooy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Van Rooy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Van Rooy more than expected).
Fields of papers citing papers by P. Van Rooy
This network shows the impact of papers produced by P. Van Rooy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Van Rooy. The network helps show where P. Van Rooy may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Van Rooy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 332 | |
| 2 | 1988 | 212 | |
| 3 | Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole. | 1996 | 96 |
| 4 | 1996 | 80 | |
| 5 | 1990 | 50 | |
| 6 | 1989 | 31 | |
| 7 | A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group. | 1992 | 20 |
| 8 | 2006 | 16 | |
| 9 | 1993 | 8 | |
| 10 | 1992 | 7 | |
| 11 | 1983 | 5 | |
| 12 | 1985 | 5 | |
| 13 | 1991 | 5 | |
| 14 | 1992 | 4 | |
| 15 | 1981 | 3 | |
| 16 | 1991 | 2 | |
| 17 | 1987 | 2 | |
| 18 | The safety and tolerability of single intravenous doses of lubeluzole (Prosynap) in healthy volunteers. | 1997 | 2 |
About P. Van Rooy
P. Van Rooy is a scholar working on Pharmacology, Physiology, Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 880 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pain Mechanisms and Treatments (2 papers), Nail Diseases and Treatments (2 papers), Optical Imaging and Spectroscopy Techniques (1 paper), Diabetes and associated disorders (1 paper), Hormonal and reproductive studies (1 paper) and Blood Pressure and Hypertension Studies (1 paper). The work is most often cited by research in Infectious Diseases (361 citations), Epidemiology (400 citations), Pharmaceutical Science (79 citations), Small Animals (74 citations) and Pharmacology (74 citations). P. Van Rooy has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include G. Cauwenbergh, R. Woestenborghs, J. Heykants, A. Van Peer, Vera Van de Velde, Karel Lavrijsen, J. Van Cutsem, W. Meuldermans, H. Degreef and Robert Woestenborghs. Their work appears in journals such as Diabetologia, The Prostate, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, European Journal of Clinical Pharmacology and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.